Top Markets
#1 TENDIES TENDIES +42.62%
#2 Cash Cat Cash Cat +27.92%
#3 ICON ICON +23.59%
#4 Asteroid Shiba Asteroid Shiba +17.29%
#5 OSK OSK +15.36%
#6 MarsCoin MarsCoin +13.78%
#7 Threshold Network Threshold Network +12.29%
#8 龙虾 (Lobster) 龙虾 (Lobster) +10.00%
#9 Tornado Cash Tornado Cash +9.69%
#10 Kite Kite +9.57%
Coin of the day
TENDIES TENDIES
設定
言語
日本
通貨
USD
テーマ
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
株式のランク #16882
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
株価
$2.52
時価総額
$274.65M
変化（1日）
0.46%
変化（1年）
-56.11%
国
CN
取引 VISEN Pharmaceuticals (2561)

カテゴリー

Healthcare
VISEN Pharmaceuticals（2561）の利益
2026 時点の利益 TTM: 0
VISEN Pharmaceuticals の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
VISEN Pharmaceuticals の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH